Page last updated: 2024-08-25

cipamfylline and Dermatitis, Atopic

cipamfylline has been researched along with Dermatitis, Atopic in 3 studies

*Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema. [MeSH]

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (33.33)29.6817
2010's2 (66.67)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Andersson, C; Engell, K; Felding, J; Hegardt, P; Ladefoged, LG; Larsen, J; Nielsen, SF; Poulsen, TD; Refer, P; Søhoel, A; Sørensen, MD; Thormann, T; Vinggaard, AM1
Alenius, H; Kemp, K; Kvist, PH; Lauerma, A; Lehto, M; Savinko, T; Wolff, H1
Gilbert, M; Griffiths, CE; Traulsen, J; Van Leent, EJ1

Reviews

1 review(s) available for cipamfylline and Dermatitis, Atopic

ArticleYear
Discovery and early clinical development of 2-{6-[2-(3,5-dichloro-4-pyridyl)acetyl]-2,3-dimethoxyphenoxy}-N-propylacetamide (LEO 29102), a soft-drug inhibitor of phosphodiesterase 4 for topical treatment of atopic dermatitis.
    Journal of medicinal chemistry, 2014, Jul-24, Volume: 57, Issue:14

    Topics: Acetamides; Crystallography, X-Ray; Cyclic Nucleotide Phosphodiesterases, Type 4; Dermatitis, Atopic; Dose-Response Relationship, Drug; Drug Discovery; Humans; Models, Molecular; Molecular Structure; Phosphodiesterase 4 Inhibitors; Pyridines; Structure-Activity Relationship

2014

Trials

1 trial(s) available for cipamfylline and Dermatitis, Atopic

ArticleYear
Randomized comparison of the type 4 phosphodiesterase inhibitor cipamfylline cream, cream vehicle and hydrocortisone 17-butyrate cream for the treatment of atopic dermatitis.
    The British journal of dermatology, 2002, Volume: 147, Issue:2

    Topics: Administration, Topical; Adult; Anti-Inflammatory Agents; Dermatitis, Atopic; Double-Blind Method; Female; Follow-Up Studies; Humans; Hydrocortisone; Male; Middle Aged; Ointments; Phosphodiesterase Inhibitors; Prospective Studies; Recurrence; Statistics, Nonparametric; Xanthines

2002

Other Studies

1 other study(ies) available for cipamfylline and Dermatitis, Atopic

ArticleYear
A murine model of epicutaneous protein sensitization is useful to study efficacies of topical drugs in atopic dermatitis.
    International immunopharmacology, 2010, Volume: 10, Issue:4

    Topics: Administration, Topical; Animals; Anti-Allergic Agents; Anti-Inflammatory Agents; Betamethasone Valerate; Calcineurin Inhibitors; Cytokines; Dermatitis, Atopic; Disease Models, Animal; Enterotoxins; Female; Immunoglobulin A; Immunoglobulin E; Immunohistochemistry; Immunosuppressive Agents; Mice; Mice, Inbred BALB C; Ovalbumin; Phosphodiesterase Inhibitors; Proteins; Reverse Transcriptase Polymerase Chain Reaction; Skin; Tacrolimus; Xanthines

2010